Patent details

EP1221966 Title: USE OF A PARATHYROID HORMONE FOR REDUCING THE RISK OF CANCER

Basic Information

Publication number:
EP1221966
PCT Application Number:
PCT/US/2000/024746
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009617143
PCT Publication Number:
WO/2001/021198
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF A PARATHYROID HORMONE FOR REDUCING THE RISK OF CANCER
French Title of Invention:
UTILISATION D'UNE HORMONE PARATHYROIDE POUR REDUIRE LES RISQUES DE CANCER
German Title of Invention:
VERWENDUNG EINER PARATHYROIDHORMONE ZUR REDUKTION DES KREBSRISIKOS
SPC Number:

Dates

Filing date:
11/09/2000
Grant date:
16/11/2005
EP Publication Date:
16/11/2005
PCT Publication Date:
29/03/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/07/2002
EP B1 Publication Date:
16/11/2005
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/09/2006
Expiration date:
11/09/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/09/2000
 
 

Name:
ELI LILLY AND COMPANY
Address:
Lilly Corporate Center, Indianapolis, Indiana 46285, United States (US)

Inventor

Name:
HOCK Janet, M.
Address:
United States (US)

Priority

Priority Number:
155455 P
Priority Date:
20/09/1999
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/29;
Filing date Document type Number of pages